Followers | 130 |
Posts | 14996 |
Boards Moderated | 1 |
Alias Born | 06/04/2018 |
Thursday, November 12, 2020 10:45:24 AM
● Immunotherapies focused on age-related disorders and autoimmune diseases entering Phase 2 clinical trials ● Lead molecule MYMD-1 inhibits production of tumor necrosis factor alpha (TNF- α ), a cell signaling protein involved in systemic inf...
Find out more AKER - Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
@whytestocks
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM